Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer's Disease in Spain.

ABSTRACT:

Introduction

The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer's disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess whether society can afford it. The objective of this study was to carry out a budget impact analysis of the use of Souvenaid in Spain under the conditions of the LipiDidiet clinical trial from a societal perspective.

Methods

We built a population model that took into account all the cohorts of individuals with AD, their individual progression, and the potential impact of Souvenaid treatment on their trajectories. Patient progression data were obtained from mixed models. The target population was estimated based on the population forecast for 2020-2035 and the incidence

SUBMITTER: Mar J 

PROVIDER: S-EPMC9652901 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature